Breaking News Instant updates and real-time market news.

GHDX

Genomic Health

$65.63

-2.07 (-3.06%)

17:06
05/07/19
05/07
17:06
05/07/19
17:06

Genomic Health reports Q1 EPS 34c, consensus 28c

Reports Q1 revenue $108.8M, consensus $106.68M.

  • 07

    May

  • 18

    Jun

  • 06

    Aug

GHDX Genomic Health
$65.63

-2.07 (-3.06%)

12/19/18
OPCO
12/19/18
INITIATION
OPCO
Perform
Genomic Health initiated with a Perform at Oppenheimer
Oppenheimer analyst Kevin DeGeeter started Genomic Health with a Perform rating. The analyst views Genomic Health as a leader in diagnostic testing for predicting response to certain therapeutics and for staging of oncology patients. However, given the strong share price appreciation since presentation of TAILORx data, DeGeeter believes the stock is fully valued.
01/02/19
NEED
01/02/19
INITIATION
Target $86
NEED
Strong Buy
Genomic Health initiated with a Strong Buy at Needham
Needham analyst Stephen Unger initiated Genomic Health with a Strong Buy rating and $86 price target, stating that he sees significant EPS upside potential from the commercialization of its expanding portfolio of molecular diagnostic testing services and a focus on profits.
02/21/19
PIPR
02/21/19
NO CHANGE
Target $86
PIPR
Neutral
Genomic Health price target raised to $86 from $64 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for Genomic Health to $86 citing increased visibility into near-term growth following the company's "solid" Q4 results. The analyst appreciates that Genomic Health is well positioned for accelerated growth in 2019 and 2020, but he keeps a Neutral rating on the shares due to valuation.
02/21/19
NEED
02/21/19
NO CHANGE
Target $97
NEED
Strong Buy
Genomic Health price target raised to $97 from $86 at Needham
Needham analyst Stephen Unger raised his price target on Genomic Health to $97 and kept his Strong Buy rating after its Q4 results and higher than expected FY19 earnings guidance. The analyst notes that the company's financial model offers "significant operating leverage" that was "clearly demonstrated" in 2018 and sees potential for earnings growth to persist this year thanks to the better than expected testing volumes of its Oncotype breast cancer test product.

TODAY'S FREE FLY STORIES

URBN

Urban Outfitters

$27.07

0.11 (0.41%)

15:19
05/21/19
05/21
15:19
05/21/19
15:19
Options
Urban Outfitters options imply 13.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 04

    Jun

WYNN

Wynn Resorts

$120.62

1.5 (1.26%)

15:17
05/21/19
05/21
15:17
05/21/19
15:17
Recommendations
Wynn Resorts analyst commentary  »

Wynn Resorts named as new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
05/21/19
05/21
15:17
05/21/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCX

OncoCyte

$5.08

-0.08 (-1.55%)

15:16
05/21/19
05/21
15:16
05/21/19
15:16
Hot Stocks
OncoCyte presents 'positive' results from R&D validation study of DetermaVu »

OncoCyte presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
05/21/19
05/21
15:16
05/21/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YPF

YPF

$15.35

(0.00%)

15:15
05/21/19
05/21
15:15
05/21/19
15:15
Options
YPF put volume heavy and directionally bearish »

Bearish flow noted in YPF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
05/21/19
05/21
15:10
05/21/19
15:10
General news
Treasury Market Summary »

Treasury Market Summary:…

JWN

Nordstrom

$37.82

0.36 (0.96%)

15:04
05/21/19
05/21
15:04
05/21/19
15:04
Options
Nordstrom options imply 11.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    May

EADSY

Airbus

$0.00

(0.00%)

15:03
05/21/19
05/21
15:03
05/21/19
15:03
Periodicals
Airbus CEO hints at launch of new A321 plane, Reuters says »

Airbus CEO Guillaume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPL

Texas Pacific Land Trust

$853.39

8.39 (0.99%)

15:02
05/21/19
05/21
15:02
05/21/19
15:02
Hot Stocks
Texas Pacific Land Trust files lawsuit against trustee Eric Oliver »

Texas Pacific Land Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$111.18

1.94 (1.78%)

15:00
05/21/19
05/21
15:00
05/21/19
15:00
Options
Lowe's options volume is 3X daily average ahead of earnings »

Lowe's options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 31

    May

MNK

Mallinckrodt

$9.55

-3.47 (-26.65%)

14:59
05/21/19
05/21
14:59
05/21/19
14:59
Recommendations
Mallinckrodt analyst commentary at Raymond James »

Mallinckrodt could lose…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$85.97

-0.26 (-0.30%)

14:58
05/21/19
05/21
14:58
05/21/19
14:58
Hot Stocks
Philip Morris announces creation of new senior management team roles »

Philip Morris…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SE

Sea Limited

$25.41

-0.39 (-1.51%)

14:49
05/21/19
05/21
14:49
05/21/19
14:49
Options
Sea Limited options imply 14.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

AAPL

Apple

$187.49

4.43 (2.42%)

14:31
05/21/19
05/21
14:31
05/21/19
14:31
Periodicals
Apple expands keyboard repair program to include butterfly mechanism, Verge says »

Apple is updating its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

CC

Chemours

$23.77

1.35 (6.02%)

14:30
05/21/19
05/21
14:30
05/21/19
14:30
Options
5K Chemours Oct 16 - 20 put spreads bought for 92c as shares rally »

5K Chemours Oct 16 - 20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
05/21/19
05/21
14:25
05/21/19
14:25
Conference/Events
Cowen biotechnology analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

QRVO

Qorvo

$62.14

0.84 (1.37%)

14:22
05/21/19
05/21
14:22
05/21/19
14:22
Recommendations
Qorvo analyst commentary at Oppenheimer »

Qorvo could be first to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PED

PEDEVCO Corp.

$2.02

-0.06 (-2.88%)

14:21
05/21/19
05/21
14:21
05/21/19
14:21
Hot Stocks
PEDEVCO Corp. announces sale of stock to SK Energy, two unaffiliated investors »

PEDEVCO Corp. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PED

PEDEVCO Corp.

$2.02

-0.06 (-2.88%)

14:20
05/21/19
05/21
14:20
05/21/19
14:20
Hot Stocks
Breaking Hot Stocks news story on PEDEVCO Corp. »

PEDEVCO Corp. trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
05/21/19
05/21
14:17
05/21/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
05/21/19
05/21
14:16
05/21/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$127.09

0.9 (0.71%)

, AAPL

Apple

$187.52

4.46 (2.44%)

14:15
05/21/19
05/21
14:15
05/21/19
14:15
Periodicals
Microsoft cuts Huawei laptop from store, Verge says »

According to a story from…

MSFT

Microsoft

$127.09

0.9 (0.71%)

AAPL

Apple

$187.52

4.46 (2.44%)

HPQ

HP Inc.

$19.55

0.6 (3.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 11

    Jun

  • 23

    Jun

  • 06

    Aug

BCRX

BioCryst

$3.45

-3.95 (-53.38%)

14:13
05/21/19
05/21
14:13
05/21/19
14:13
Recommendations
BioCryst analyst commentary at JMP Securities »

BioCryst pullback an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

XRX

Xerox

$32.83

0.705 (2.19%)

14:12
05/21/19
05/21
14:12
05/21/19
14:12
Hot Stocks
Xerox shareholders approve holding company reorganization »

Xerox announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.